-+ 0.00%
-+ 0.00%
-+ 0.00%

D. Boral Capital Maintains Buy on MediciNova, Maintains $9 Price Target

Benzinga·04/09/2025 11:16:42
Listen to the news
D. Boral Capital analyst Jason Kolbert maintains MediciNova (NASDAQ:MNOV) with a Buy and maintains $9 price target.